Skip to main content
. 2017 Nov 29;6(12):e007034. doi: 10.1161/JAHA.117.007034

Figure 5.

Figure 5

Cumulative risks of the ischemic or hemorrhagic end point for the non–vitamin K oral anticoagulants.